+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton pump inhibitors increase the risk of cholecystitis: a population-based case-control study



Proton pump inhibitors increase the risk of cholecystitis: a population-based case-control study



Gut 2018




(PDF emailed within 0-6 h: $19.90)

Accession: 065445508

Download citation: RISBibTeXText

PMID: 30018164

DOI: 10.1136/gutjnl-2018-316899


Related references

Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study. Journal of Internal Medicine 2018, 2018

Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study. Pharmacoepidemiology and Drug Safety 19(11): 1131-1136, 2011

Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study. Osteoporosis International 22(3): 903-910, 2011

Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Archives of Internal Medicine 167(9): 950-955, 2007

Association Between the Use of Proton Pump Inhibitors and the Risk of ESRD in Renal Diseases: A Population-Based, Case-Control Study. Medicine 95(15): E3363, 2016

Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study. Pharmacoepidemiology and Drug Safety 19(8): 792-802, 2011

Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study. Drug Safety 38(12): 1187-1199, 2016

Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study. Plos Medicine 11(9): E1001736, 2015

Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study. European Journal of Internal Medicine 2018, 2018

Use of Proton Pump Inhibitors and the Risk of Listeriosis: A Nationwide Registry-based Case-Control Study. Clinical Infectious Diseases 64(7): 845-851, 2016

A population-based case-control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate. Journal of Gastroenterology 48(9): 1016-1022, 2014

Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study. Gastroenterology 133(3): 755-760, 2007

Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study. Gastroenterology 152(1): 134-141, 2016

Proton pump inhibitors and risk of gastric cancer: a population-based cohort study. Yearbook of Medicine 2010: 435-436, 2010

Use of Proton Pump Inhibitors and Risk of Major Depressive Disorder: A Nationwide Population-Based Study. PsychoTherapy and Psychosomatics 87(1): 62-64, 2018